|
Dr Reddy’s R&D centre which is the Integrated Product Development Organisation (IPDO) located at Bachupally, Hyderabad, underwent a GMP and Pre-Approval Inspection (PAI) by the US FDA in December 2023. The US FDA has now classified that inspection too as Voluntary Action Indicated (VAI).
This is the second piece of good news in recent days. On February 10, the company stated that it had updated that the US FDA had issued VAI status to FTO-3, our largest formulations manufacturing plant also in Bachupally and concluded the inspection as closed, stated the Hyderabad-based pharma major.
|